Arcturus Share Price
NASDAQ: ARCT | Micro Cap | HealthcareArcturus Stock Performance
Arcturus Share Price Today
As of 19 November 2026, Arcturus Therapeutics Holdings Inc.'s share price is $7.86. The stock opened at $8.09, compared to its previous close of $7.98. During today's trading session, Arcturus Therapeutics Holdings Inc.'s share price traded between $7.83 and $8.53, with an average price of $8.18. Over the past 52 weeks, the stock has recorded a high of $17.90 and a low of $5.50. In terms of performance, Arcturus Therapeutics Holdings Inc.'s share price has declined by 1.01% over the last six months and is up 16.10% on a year-on-year basis.
Arcturus Share Price Chart
Arcturus Quarterly Profit & Loss
All figures in USD
Arcturus Annual Profit & Loss
All figures in USD
Arcturus Balance Sheet
All figures in USD Million
Arcturus Cash Flow
All figures in USD Million
About Arcturus
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Arcturus Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $10.65 | $7.86 | -28.55% |
Oct 2026 | $13.47 | $11.00 | -19.88% |
Sep 2026 | $15.13 | $13.73 | -15.14% |
Aug 2026 | $5.86 | $16.18 | +181.15% |
Jul 2026 | $6.83 | $5.75 | -14.23% |
Jun 2026 | $7.71 | $6.71 | -15.49% |
May 2026 | $8.54 | $7.94 | -7.89% |
Apr 2026 | $7.99 | $8.62 | +11.51% |
Mar 2026 | $8.07 | $7.73 | -6.30% |
Feb 2026 | $7.37 | $8.25 | +10.15% |
Jan 2026 | $6.19 | $7.49 | +22.59% |
Dec 2025 | $6.47 | $6.11 | -9.75% |